Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival

被引：0
|
作者：
Tyler C. Haddad
Songzhu Zhao
Mingjia Li
Sandip H. Patel
Andrew Johns
Madison Grogan
Gabriella Lopez
Abdul Miah
Lai Wei
Gabriel Tinoco
Brian Riesenberg
Zihai Li
Alexa Meara
Erin M. Bertino
Kari Kendra
Gregory Otterson
Carolyn J. Presley
Dwight H. Owen
机构：
[1] The Ohio State University - James Comprehensive Cancer Center, Division of Medical Oncology, Department of Internal Medicine
[2] The Ohio State University - James Comprehensive Cancer Center,Center for Biostatistics
[3] The Ohio State University - James Comprehensive Cancer Center,Division of Rheumatology and Immunology
来源：
Cancer Immunology, Immunotherapy | 2022年 / 71卷
关键词：
Immune checkpoint inhibitor (ICI); Immunotherapy; Thrombocytopenia; Immune-related adverse events (irAE);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1157 / 1165
页数：8
相关论文
共 50 条
  • [1] Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival
    Haddad, Tyler C.
    Zhao, Songzhu
    Li, Mingjia
    Patel, Sandip H.
    Johns, Andrew
    Grogan, Madison
    Lopez, Gabriella
    Miah, Abdul
    Wei, Lai
    Tinoco, Gabriel
    Riesenberg, Brian
    Li, Zihai
    Meara, Alexa
    Bertino, Erin M.
    Kendra, Kari
    Otterson, Gregory
    Presley, Carolyn J.
    Owen, Dwight H.
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (05) : 1157 - 1165
  • [2] Immune checkpoint inhibitor-related thrombocytopenia: Incidence, risk factors, and effect on overall survival.
    Haddad, Tyler
    Zhao, Songzhu
    Li, Mingjia
    Patel, Sandip H.
    Johns, Andrew
    Grogan, Madison
    Lopez, Gabrielle
    Miah, Abdul
    Wei, Lai
    Tinoco, Gabriel
    Riesenberg, Brian P.
    Li, Zihai
    Bertino, Erin Marie
    Kendra, Kari Lynn
    Otterson, Gregory Alan
    Presley, Carolyn J.
    Owen, Dwight Hall
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [3] The Risk Factors Associated with Immune Checkpoint Inhibitor-Related Pneumonitis
    Asada, Mizuho
    Mikami, Takahisa
    Niimura, Takahiro
    Zamami, Yoshito
    Uesawa, Yoshihiro
    Chuma, Masayuki
    Ishizawa, Keisuke
    [J]. ONCOLOGY, 2021, 99 (04) : 256 - 259
  • [4] Incidence and Prediction of Immune Checkpoint Inhibitor-related Nephrotoxicity
    Sorah, Jonathan D.
    Rose, Tracy L.
    Radhakrishna, Roshni
    Derebail, Vimal K.
    Milowsky, Matthew, I
    [J]. JOURNAL OF IMMUNOTHERAPY, 2021, 44 (03) : 127 - 131
  • [5] Factors Associated With Immune Checkpoint Inhibitor-Related Myocarditis
    Zamami, Yoshito
    Niimura, Takahiro
    Okada, Naoto
    Koyama, Toshihiro
    Fukushima, Keijo
    Izawa-Ishizawa, Yuki
    Ishizawa, Keisuke
    [J]. JAMA ONCOLOGY, 2019, 5 (11) : 1635 - 1637
  • [6] Immune checkpoint inhibitor-related risk of pulmonary AEs
    [J]. Reactions Weekly, 2024, 1997 (1) : 12 - 12
  • [7] Incidence and Effect Duration of Immune Checkpoint Inhibitor-Related Pancreas Adverse Events
    Gleeson, Ferga C.
    Dunleavy, Katie A.
    Levy, Michael J.
    Carr, Ryan M.
    Hartgers, Mindy L.
    Kottschade, Lisa A.
    Mcwilliams, Robert R.
    Ma, Wen Wee
    Kudva, Yogish C.
    Egan, Aoife M.
    [J]. PANCREAS, 2024, 53 (07) : e627 - e629
  • [8] Incidence and outcomes of immune checkpoint inhibitor-related myositis.
    Aldrich, Jeffrey
    Pundole, Xerxes
    Tummala, Sudhakar
    Andersen, Clark
    Shoukier, Mahran
    Abdel-Wahab, Noha
    Palaskas, Nicolas
    Deswal, Anita
    Suarez-Almazor, Maria E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [9] Incidence of Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer
    Poulose, Vijo
    [J]. CHEST, 2022, 161 (03) : E196 - E197
  • [10] Immune Checkpoint Inhibitor-Related Pneumonitis
    Gomatou, Georgia
    Tzilas, Vasilios
    Kotteas, Elias
    Syrigos, Konstantinos
    Bouros, Demosthenes
    [J]. RESPIRATION, 2021, 99 (11) : 932 - 942
12345